288 related articles for article (PubMed ID: 25987254)
1. Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo.
Morelli E; Leone E; Cantafio ME; Di Martino MT; Amodio N; Biamonte L; Gullà A; Foresta U; Pitari MR; Botta C; Rossi M; Neri A; Munshi NC; Anderson KC; Tagliaferri P; Tassone P
Leukemia; 2015 Nov; 29(11):2173-83. PubMed ID: 25987254
[TBL] [Abstract][Full Text] [Related]
2. A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells.
Leotta M; Biamonte L; Raimondi L; Ronchetti D; Di Martino MT; Botta C; Leone E; Pitari MR; Neri A; Giordano A; Tagliaferri P; Tassone P; Amodio N
J Cell Physiol; 2014 Dec; 229(12):2106-16. PubMed ID: 24819167
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplay.
Abruzzese MP; Bilotta MT; Fionda C; Zingoni A; Soriani A; Vulpis E; Borrelli C; Zitti B; Petrucci MT; Ricciardi MR; Molfetta R; Paolini R; Santoni A; Cippitelli M
J Hematol Oncol; 2016 Dec; 9(1):134. PubMed ID: 27903272
[TBL] [Abstract][Full Text] [Related]
4. Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence.
Di Martino MT; Leone E; Amodio N; Foresta U; Lionetti M; Pitari MR; Cantafio ME; Gullà A; Conforti F; Morelli E; Tomaino V; Rossi M; Negrini M; Ferrarini M; Caraglia M; Shammas MA; Munshi NC; Anderson KC; Neri A; Tagliaferri P; Tassone P
Clin Cancer Res; 2012 Nov; 18(22):6260-70. PubMed ID: 23035210
[TBL] [Abstract][Full Text] [Related]
5. Ectopic microRNA-150-5p transcription sensitizes glucocorticoid therapy response in MM1S multiple myeloma cells but fails to overcome hormone therapy resistance in MM1R cells.
Palagani A; Op de Beeck K; Naulaerts S; Diddens J; Sekhar Chirumamilla C; Van Camp G; Laukens K; Heyninck K; Gerlo S; Mestdagh P; Vandesompele J; Berghe WV
PLoS One; 2014; 9(12):e113842. PubMed ID: 25474406
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of microRNA-125b-5p is involved in the pathogenesis of osteoarthritis by downregulating SYVN1.
Ge FX; Li H; Yin X
Oncol Rep; 2017 Apr; 37(4):2490-2496. PubMed ID: 28260078
[TBL] [Abstract][Full Text] [Related]
7. Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth.
Leone E; Morelli E; Di Martino MT; Amodio N; Foresta U; Gullà A; Rossi M; Neri A; Giordano A; Munshi NC; Anderson KC; Tagliaferri P; Tassone P
Clin Cancer Res; 2013 Apr; 19(8):2096-106. PubMed ID: 23446999
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-125b-5p inhibits proliferation and promotes adipogenic differentiation in 3T3-L1 preadipocytes.
Ouyang D; Ye Y; Guo D; Yu X; Chen J; Qi J; Tan X; Zhang Y; Ma Y; Li Y
Acta Biochim Biophys Sin (Shanghai); 2015 May; 47(5):355-61. PubMed ID: 25918183
[TBL] [Abstract][Full Text] [Related]
9. PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4.
Ueno N; Nishimura N; Ueno S; Endo S; Tatetsu H; Hirata S; Hata H; Matsuoka M; Mitsuya H; Okuno Y
Oncogene; 2017 Aug; 36(31):4481-4497. PubMed ID: 28368411
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of MicroRNA-125b-5p and Transcription Factors BLIMP1 and IRF4 Expression in Unsolved Common Variable Immunodeficiency Patients.
Hamidi Esfahani Z; Yazdani R; Shahkarami S; Babaha F; Abolhassani H; Sadr M; Pourfathollah AA; Aghamohammadi A
Iran J Allergy Asthma Immunol; 2021 Dec; 20(6):700-710. PubMed ID: 34920653
[TBL] [Abstract][Full Text] [Related]
11. A carvedilol-responsive microRNA, miR-125b-5p protects the heart from acute myocardial infarction by repressing pro-apoptotic bak1 and klf13 in cardiomyocytes.
Bayoumi AS; Park KM; Wang Y; Teoh JP; Aonuma T; Tang Y; Su H; Weintraub NL; Kim IM
J Mol Cell Cardiol; 2018 Jan; 114():72-82. PubMed ID: 29122578
[TBL] [Abstract][Full Text] [Related]
12. microRNA-155-5p initiates childhood acute lymphoblastic leukemia by regulating the IRF4/CDK6/CBL axis.
Sun X; Guan G; Dai Y; Zhao P; Liu L; Wang Q; Li X
Lab Invest; 2022 Apr; 102(4):411-421. PubMed ID: 34775495
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-125b-5p improves pancreatic β-cell function through inhibiting JNK signaling pathway by targeting DACT1 in mice with type 2 diabetes mellitus.
Yu CY; Yang CY; Rui ZL
Life Sci; 2019 May; 224():67-75. PubMed ID: 30684546
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3.
Huang L; Luo J; Cai Q; Pan Q; Zeng H; Guo Z; Dong W; Huang J; Lin T
Int J Cancer; 2011 Apr; 128(8):1758-69. PubMed ID: 20549700
[TBL] [Abstract][Full Text] [Related]
15. A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells.
Gullà A; Di Martino MT; Gallo Cantafio ME; Morelli E; Amodio N; Botta C; Pitari MR; Lio SG; Britti D; Stamato MA; Hideshima T; Munshi NC; Anderson KC; Tagliaferri P; Tassone P
Clin Cancer Res; 2016 Mar; 22(5):1222-33. PubMed ID: 26527748
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R.
Gong J; Zhang JP; Li B; Zeng C; You K; Chen MX; Yuan Y; Zhuang SM
Oncogene; 2013 Jun; 32(25):3071-9. PubMed ID: 22824797
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT
Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression.
Murray MY; Rushworth SA; Zaitseva L; Bowles KM; Macewan DJ
Cell Cycle; 2013 Jul; 12(13):2144-53. PubMed ID: 23759586
[TBL] [Abstract][Full Text] [Related]
19. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.
Kim JK; Noh JH; Jung KH; Eun JW; Bae HJ; Kim MG; Chang YG; Shen Q; Park WS; Lee JY; Borlak J; Nam SW
Hepatology; 2013 Mar; 57(3):1055-67. PubMed ID: 23079745
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-125b-5p attenuates lipopolysaccharide-induced monocyte chemoattractant protein-1 production by targeting inhibiting LACTB in THP-1 macrophages.
Lu JB; Yao XX; Xiu JC; Hu YW
Arch Biochem Biophys; 2016 Jan; 590():64-71. PubMed ID: 26603571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
